Literature DB >> 15743915

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

Sébastien Lacroix-Desmazes1, Jagadeesh Bayry, Srini V Kaveri, David Hayon-Sonsino, Nithyananda Thorenoor, Julien Charpentier, Charles-Edouard Luyt, Jean-Paul Mira, Valakunja Nagaraja, Michel D Kazatchkine, Jean-François Dhainaut, Vincent O Mallet.   

Abstract

Sepsis is the leading cause of death in intensive care units and results from a deleterious systemic host response to infection. Although initially perceived as potentially deleterious, catalytic antibodies have been proposed to participate in removal of metabolic wastes and protection against infection. Here we show that the presence in plasma of IgG endowed with serine protease-like hydrolytic activity strongly correlates with survival from sepsis. Variances of catalytic rates of IgG were greater in the case of patients with severe sepsis than healthy donors (P < 0.001), indicating that sepsis is associated with alterations in plasma levels of hydrolytic IgG. The catalytic rates of IgG from patients who survived were significantly greater than those of IgG from deceased patients (P < 0.05). The cumulative rate of survival was higher among patients exhibiting high rates of IgG-mediated hydrolysis as compared with patients with low hydrolytic rates (P < 0.05). An inverse correlation was also observed between the markers of severity of disseminated intravascular coagulation and rates of hydrolysis of patients' IgG. Furthermore, IgG from three surviving patients hydrolyzed factor VIII, one of which also hydrolyzed factor IX, suggesting that, in some patients, catalytic IgG may participate in the control of disseminated microvascular thrombosis. Our observations provide the first evidence that hydrolytic antibodies might play a role in recovery from a disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743915      PMCID: PMC554824          DOI: 10.1073/pnas.0500586102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Control of early viral and bacterial distribution and disease by natural antibodies.

Authors:  A F Ochsenbein; T Fehr; C Lutz; M Suter; F Brombacher; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  A possible role of catalytic antibodies in metabolism.

Authors:  A Friboulet; B Avalle; H Débat; D Thomas
Journal:  Immunol Today       Date:  1999-10

3.  Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity.

Authors:  A V Kozyr; A V Kolesnikov; N A Zelenova; L P Sashchenko; S V Mikhalap; M E Bulina; A N Ignatova; P V Favorov; A G Gabibov
Journal:  Appl Biochem Biotechnol       Date:  2000 Jan-Mar       Impact factor: 2.926

4.  Immunology. Catalytic antibody bridges innate and adaptive immunity.

Authors:  Carl Nathan
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

5.  Monoclonal antibody light chain with prothrombinase activity.

Authors:  P Thiagarajan; R Dannenbring; K Matsuura; A Tramontano; G Gololobov; S Paul
Journal:  Biochemistry       Date:  2000-05-30       Impact factor: 3.162

6.  Prothrombin time and activated partial thromboplastin time can be performed on the first tube.

Authors:  E L Gottfried; M M Adachi
Journal:  Am J Clin Pathol       Date:  1997-06       Impact factor: 2.493

7.  Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease.

Authors:  S Paul; L Li; R Kalaga; J O'Dell; R E Dannenbring; S Swindells; S Hinrichs; P Caturegli; N R Rose
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

8.  Catalytic activity of antibodies against factor VIII in patients with hemophilia A.

Authors:  S Lacroix-Desmazes; A Moreau; C Bonnemain; N Stieltjes; A Pashov; Y Sultan; J Hoebeke; M D Kazatchkine; S V Kaveri
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

9.  Characterization and selectivity of catalytic antibodies from human serum with RNase activity.

Authors:  A Vlassov; C Florentz; M Helm; V Naumov; V Buneva; G Nevinsky; R Giegé
Journal:  Nucleic Acids Res       Date:  1998-12-01       Impact factor: 16.971

10.  DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers.

Authors:  T G Kanyshkova; D V Semenov; V N Buneva; G A Nevinsky
Journal:  FEBS Lett       Date:  1997-10-13       Impact factor: 4.124

View more
  25 in total

Review 1.  Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

2.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

3.  A human germ line antibody light chain with hydrolytic properties associated with multimerization status.

Authors:  Vikram Sharma; William Heriot; Kirk Trisler; Vaughn Smider
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

Review 4.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

Review 5.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

6.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 7.  Antibody-Mediated Catalysis in Infection and Immunity.

Authors:  Anthony Bowen; Maggie Wear; Arturo Casadevall
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

8.  Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.

Authors:  Stéphanie Barnay-Verdier; Lakhdar Fattoum; Chloé Borde; Srini Kaveri; Sébastien Gibot; Vincent Maréchal
Journal:  Intensive Care Med       Date:  2011-02-26       Impact factor: 17.440

Review 9.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

10.  Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Authors:  Ankit Mahendra; Ivan Peyron; Olivier Thaunat; Cécile Dollinger; Laurent Gilardin; Meenu Sharma; Bharath Wootla; Desirazu N Rao; Séverine Padiolleau-Lefevre; Didier Boquet; Abhijit More; Navin Varadarajan; Srini V Kaveri; Christophe Legendre; Sébastien Lacroix-Desmazes
Journal:  J Immunol       Date:  2016-04-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.